Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07363421 · ClinicalTrials.gov registry record · NA
TMS-Induced LH Response in Healthy Women in Luteal Phase
A NA study of Healthy Women, sponsored by The City College of New York.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07363421: Recruiting NA study of Healthy Women, sponsored by The City College of New York.
NCT07363421 is a NA study of Healthy Women that is actively recruiting participants, run by The City College of New York. The registered enrollment target is 10 participants, below the 62-participant average among 4 other Healthy Women trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07363421, a NA study of Healthy Women, is actively recruiting participants, sponsored by The City College of New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to establish whether non-invasive Transcranial Magnetic Stimulation (TMS), can affect modulation of hormones such: Luteinizing Hormone (LH) and Follicle-stimulating hormone (FSH). The hypothesis is that applying TMS to the Dorsolateral Prefrontal Cortex with specific pulse patterns, mimicking endogenous Gonodotropin-Releasing Hormone (GnRH) pulses that are known to stimulate LH secretion may modulate hormonal levels.
Primary Outcome
Change in serum LH and FSH concentrations across six time points. Blood samples will be collected via venipuncture. LH and FSH levels will be quantified in IU/L. The primary analysis will evaluate within-subject changes in LH and FSH across the six sampling points and compare hormonal trajectories between active TMS and sham.
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation Sham
- DEVICE Transcranial Magnetic Stimulation Active
Study Locations (1)
New York
- Site 1 - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT07363421 shows while recruiting
NCT07363421 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 62-participant average among 4 other Healthy Women trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Healthy Women appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation Sham is the first listed.
NCT07363421 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07363421 about?
NCT07363421 is a clinical study titled "TMS-Induced LH Response in Healthy Women in Luteal Phase". The purpose of this research is to establish whether non-invasive Transcranial Magnetic Stimulation (TMS), can affect modulation of hormones such: Luteinizing Hormone (LH) and Follicle-stimulating hormone (FSH). The hypothesis is that applying TMS to the Dorsolateral Prefrontal Cortex with specific...
What is the current status of trial NCT07363421?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-02-24. Estimated completion is 2026-06-01.
What conditions does trial NCT07363421 study?
This clinical trial studies the following conditions: Healthy Women.
What interventions are being tested in trial NCT07363421?
The interventions under investigation include: Transcranial Magnetic Stimulation Sham (DEVICE), Transcranial Magnetic Stimulation Active (DEVICE).
Who is sponsoring clinical trial NCT07363421?
This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07363421 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Women
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Intensity, Metabolic Rate and Insulin Sensitivity
COMPLETED · NA
-
The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise
RECRUITING
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
ACTIVE NOT RECRUITING · Phase 1
-
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI